Sonographic Examination of Median Nerve Variations
Launched by YUNUS BURAK BAYIR · Aug 1, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a specific condition called Carpal Tunnel Syndrome (CTS), which causes pain and numbness in the hand due to pressure on the median nerve. The main goal of the study is to find out how common a particular variation of the median nerve, known as a bifid median nerve, is in people with CTS compared to those without any symptoms. Researchers hope to understand if this nerve variation might lead to the development of CTS in some individuals.
To participate in this study, you need to be at least 18 years old and have had symptoms of Carpal Tunnel Syndrome for more than three months, confirmed by a test called EMG. However, individuals with certain health issues, like diabetes or previous nerve problems, cannot join. If you take part in this trial, you will help researchers learn more about the potential causes of CTS, which could lead to better treatments in the future. The study is not yet recruiting participants, but it aims to provide valuable insights into the relationship between the median nerve's structure and CTS.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having typical Carpal Tunnel Sydnrome symptoms lasting longer than 3 months
- • Carpal tunnel syndrome diagnosed with EMG
- • Being a male/female \>18 years of age
- Exclusion Criteria:
- • History of polyneuropathy, brachial plexopathy, thoracic outlet syndrome, or surgery in the wrist area
- • Presence of inflammatory arthritis, hypothyroidism, pregnancy, rheumatological disorders, diabetes mellitus
- • Presence of peripheral vascular disease
About Yunus Burak Bayır
Yunus Burak Bayır is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing effective therapeutic solutions, the organization collaborates with healthcare professionals and research institutions to design and implement rigorous clinical trials. Leveraging a strong foundation in scientific expertise and regulatory compliance, Yunus Burak Bayır aims to enhance patient care by bringing new treatments to market while prioritizing safety and ethical standards in all research activities. Through strategic partnerships and a commitment to excellence, the sponsor plays a pivotal role in the progression of clinical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Başak MANSIZ KAPLAN, assoc. prof.
Study Chair
Ankara Etlik City Hospital
Ebru KARACA UMAY, prof. dr.
Study Chair
Ankara Etlik City Hospital
Ajda BAL, prof. dr.
Study Chair
Ankara Etlik City Hospital
Selin ÇELEBİER, assistant dr
Study Chair
Ankara Etlik Şehir Hastanesi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported